660 related articles for article (PubMed ID: 15383183)
21. [An open study on the efficacy and tolerability of quetiapine treatment of patients with schizophrenia].
Beszłej JA; Grzesiak M
Psychiatr Pol; 2005; 39(2):293-307. PubMed ID: 15881624
[TBL] [Abstract][Full Text] [Related]
22. Quetiapine in combination with citalopram in patients with unipolar psychotic depression.
Konstantinidis A; Hrubos W; Nirnberger G; Windhager E; Lehofer M; Aschauer H; Kasper S
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):242-7. PubMed ID: 16962224
[TBL] [Abstract][Full Text] [Related]
23. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S
Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848
[TBL] [Abstract][Full Text] [Related]
24. A failed 6-week,randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned.
Cutler AJ; Tran-Johnson T; Kalali A; Aström M; Brecher M; Meulien D
Psychopharmacol Bull; 2010; 43(4):37-69. PubMed ID: 21240151
[TBL] [Abstract][Full Text] [Related]
25. Improvement without impairment: a review of clinical data for quetiapine in the treatment of schizophrenia.
Tandon R
J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S15-20. PubMed ID: 12832945
[TBL] [Abstract][Full Text] [Related]
26. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
Sussman N; Mullen J; Paulsson B; Vågerö M
J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
[TBL] [Abstract][Full Text] [Related]
27. [Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study].
Leweke FM; Gerth CW; Koethe D; Nolden BM; Klosterkötter J
Fortschr Neurol Psychiatr; 2007 Apr; 75(4):211-9. PubMed ID: 17230308
[TBL] [Abstract][Full Text] [Related]
28. Quetiapine has a direct effect on the negative symptoms of schizophrenia.
Tandon R
Hum Psychopharmacol; 2004 Dec; 19(8):559-63. PubMed ID: 15486960
[TBL] [Abstract][Full Text] [Related]
29. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
[TBL] [Abstract][Full Text] [Related]
30. A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder.
Honer WG; MacEwan GW; Gendron A; Stip E; Labelle A; Williams R; Eriksson H;
J Clin Psychiatry; 2012 Jan; 73(1):13-20. PubMed ID: 21733490
[TBL] [Abstract][Full Text] [Related]
31. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
[TBL] [Abstract][Full Text] [Related]
32. The efficacy and tolerability of once-daily extended release quetiapine fumarate in hospitalized patients with acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled study.
Lindenmayer JP; Brown D; Liu S; Brecher M; Meulien D
Psychopharmacol Bull; 2008; 41(3):11-35. PubMed ID: 18779774
[TBL] [Abstract][Full Text] [Related]
33. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania.
Ketter TA; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S45-53. PubMed ID: 17383011
[TBL] [Abstract][Full Text] [Related]
34. Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies.
Suppes T; Hirschfeld RM; Vieta E; Raines S; Paulsson B
World J Biol Psychiatry; 2008; 9(3):198-211. PubMed ID: 17853277
[TBL] [Abstract][Full Text] [Related]
35. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
Arvanitis LA; Miller BG
Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
[TBL] [Abstract][Full Text] [Related]
36. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
[TBL] [Abstract][Full Text] [Related]
37. Quetiapine : A Review of its Use in Schizophrenia.
Gunasekara NS; Spencer CM
CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
[TBL] [Abstract][Full Text] [Related]
38. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
39. Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial.
McIntyre RS; Brecher M; Paulsson B; Huizar K; Mullen J
Eur Neuropsychopharmacol; 2005 Oct; 15(5):573-85. PubMed ID: 16139175
[TBL] [Abstract][Full Text] [Related]
40. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE
J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
